Committee header
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA CALIFORNIA INITIATIVE FUND
Active cycles
Panel 2 • Finance overview
Committee finance snapshot
Scope: 2021-2022 cycle
Money over time
Dated receipts only; unitemized reporting intervals are not allocated to dates.
Panel 3 • Money structure snapshot
Money structure snapshot
$5,000+ is the largest bucket at 100% of dated attributable receipts.
Dominant category: Operations at 94.3% of spending.
Donor count
24
Contributions
29
Median
$11,900
Average
$11,900
Funding distribution
$5,000+
Count: 29
Share: 100%
Amount: $345,100
Panel 5 • Financial evidence
Filings workspace
Filing history and transaction-level evidence moved to a dedicated page.
Open filings page| 29 |
| $345,100 |
| 100% |
Spending categories
Operations
Amount: $202,500
Share: 94.3%
Consulting
Amount: $12,221
Share: 5.7%
Panel 4 • Top donors
Top donors
| Donor | Total | Share* | Count | Last |
|---|---|---|---|---|
| ABBVIE INC. | $23,800 | 6.9% | 2 | May 10, 2022 |
| AMGEN INC. | $23,800 | 6.9% | 2 | Jul 11, 2022 |
| BAYER US, LLC(HALLIE UTLEY) | $23,800 | 6.9% | 2 | Mar 15, 2022 |
| GENENTECH | $23,800 | 6.9% | 2 | Mar 15, 2022 |
| UCB, INC. | $23,800 | 6.9% | 2 | Mar 15, 2022 |
| ASTELLAS PHARMA | $11,900 | 3.4% | 1 | Mar 15, 2022 |
| ASTELLAS PHARMA US, INC. | $11,900 | 3.4% | 1 | Mar 5, 2021 |
| BRISTOL-MYERS SQUIBB COMPANY | $11,900 | 3.4% | 1 | Apr 29, 2021 |
| BRISTOL-MYERS SQUIBB COMPANY | $11,900 | 3.4% | 1 | Mar 15, 2022 |
| EISAI INC. | $11,900 | 3.4% | 1 | Mar 15, 2022 |
| EISAI INC. | $11,900 | 3.4% | 1 | Mar 5, 2021 |
| ELI LILLY AND COMPANY | $11,900 | 3.4% | 1 | Mar 15, 2022 |
| ELI LILLY AND COMPANY | $11,900 | 3.4% | 1 | Mar 5, 2021 |
| GLAXOSMITHKLINE | $11,900 | 3.4% | 1 | May 10, 2022 |
| LUNDBECK INC. | $11,900 | 3.4% | 1 | Mar 5, 2021 |
| LUNDBECK INC. | $11,900 | 3.4% | 1 | May 10, 2022 |
| MERCK & CO., INC. | $11,900 | 3.4% | 1 | Aug 2, 2022 |
| MERCK & CO., INC. | $11,900 | 3.4% | 1 | Mar 5, 2021 |
| NOVARTIS | $11,900 | 3.4% | 1 | Mar 15, 2022 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $11,900 | 3.4% | 1 | Jun 17, 2021 |
| SANOFI | $11,900 | 3.4% | 1 | May 10, 2022 |
| SANOFI-AVENTIS U.S. LLC | $11,900 | 3.4% | 1 | Mar 5, 2021 |
| TAKEDA PHARMACEUTICALS AMERICA, INC. | $11,900 | 3.4% | 1 | Mar 15, 2022 |
| TAKEDA PHARMACEUTICALS U.S.A., INC. | $11,900 | 3.4% | 1 | Jun 17, 2021 |
* Share is percent of committee total raised in the selected scope. Page rows are a subset and typically do not sum to 100%.